Related Experiment Video
Updated: Dec 27, 2025
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
3.1K
When does diabetes start? Early detection and intervention in type2 diabetes mellitus
F Gómez-Peralta1, C Abreu1, X Cos2
1Unidad de Endocrinología y Nutrición, Hospital General de Segovia, Segovia, España.
Revista Clinica Espanola
|February 29, 2020
Summary
Early intervention for type 2 diabetes mellitus (DM2) is crucial. The VERIFY study shows that combining metformin and vildagliptin early improves long-term blood sugar control and disease progression.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Clinical Research
Background:
- Type 2 diabetes mellitus (DM2) is a progressive condition with pre-diagnostic pathophysiological changes.
- Early intervention is vital to prevent beta-cell dysfunction and manage cardiovascular risk factors before diagnosis.
- Current diagnostic thresholds for DM2 may be reached after significant disease progression.
Purpose of the Study:
- To evaluate the impact of early combination therapy in recently diagnosed DM2 patients.
- To assess the long-term effects of metformin-vildagliptin on glycaemic control and disease progression.
Main Methods:
- The VERIFY study investigated early treatment strategies for DM2.
- Utilized a combination therapy of metformin and vildagliptin in newly diagnosed patients.
Main Results:
- Early combination therapy with metformin-vildagliptin demonstrated significant improvements in long-term glycaemic control.
- The treatment regimen positively influenced the progression of type 2 diabetes mellitus.
Conclusions:
- Early and intensive intervention in DM2 is essential.
- Metformin-vildagliptin combination therapy offers a beneficial approach for managing recently diagnosed type 2 diabetes mellitus.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
01:15Diabetes: Management and Pharmacotherapy
787
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
787
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
01:36Carbohydrate Metabolism
13.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
01:20Pathophysiology of Diabetes
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K